IL-2 and IL-15 regulate CD154 expression on activated CD4 T cells
- PMID: 10725703
- DOI: 10.4049/jimmunol.164.7.3500
IL-2 and IL-15 regulate CD154 expression on activated CD4 T cells
Abstract
The cellular and humoral immune system is critically dependent upon CD40-CD154 (CD40 ligand) interactions between CD40 expressed on B cells, macrophages, and dendritic cells, and CD154 expressed primarily on CD4 T cells. Previous studies have shown that CD154 is transiently expressed on CD4 T cells after T cell receptor engagement in vitro. However, we found that stimulation of PBLs with maximal CD28 costimulation, using beads coupled to Abs against CD3 and CD28, led to a very prolonged expression of CD154 on CD4 cells (>4 days) that was dependent upon autocrine IL-2 production. Previously activated CD4 T cells could respond to IL-2, or the related cytokine IL-15, by de novo CD154 production and expression without requiring an additional signal from CD3 and CD28. These results provide evidence that CD28 costimulation of CD4 T cells, through autocrine IL-2 production, maintains high levels of CD154 expression. This has significant impact on our understanding of the acquired immune response and may provide insight concerning the mechanisms underlying several immunological diseases.
Similar articles
-
CD40 ligand trimer and IL-12 enhance peripheral blood mononuclear cells and CD4+ T cell proliferation and production of IFN-gamma in response to p24 antigen in HIV-infected individuals: potential contribution of anergy to HIV-specific unresponsiveness.J Immunol. 2000 Aug 1;165(3):1685-91. doi: 10.4049/jimmunol.165.3.1685. J Immunol. 2000. PMID: 10903780
-
CD28 and inducible costimulator (ICOS) signalling can sustain CD154 expression on activated T cells.Immunology. 2009 Jul;127(3):373-85. doi: 10.1111/j.1365-2567.2008.02991.x. Epub 2008 Dec 13. Immunology. 2009. PMID: 19191918 Free PMC article.
-
Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation.Int Immunol. 2003 Dec;15(12):1461-72. doi: 10.1093/intimm/dxg145. Int Immunol. 2003. PMID: 14645155
-
Central role for CD40/CD40 ligand (CD154) interactions in transplant rejection.Pediatr Transplant. 1998 Feb;2(1):6-15. Pediatr Transplant. 1998. PMID: 10084754 Review.
-
Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis.Cells. 2019 Aug 18;8(8):927. doi: 10.3390/cells8080927. Cells. 2019. PMID: 31426619 Free PMC article. Review.
Cited by
-
Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.J Immunol. 2000 Jul 15;165(2):786-94. doi: 10.4049/jimmunol.165.2.786. J Immunol. 2000. PMID: 10878352 Free PMC article.
-
Novel roles for IL-15 in T cell survival.F1000 Biol Rep. 2010 Sep 8;2:67. doi: 10.3410/B2-67. F1000 Biol Rep. 2010. PMID: 21173876 Free PMC article.
-
The effect of age on the cognate function of CD4+ T cells.Immunol Rev. 2005 Jun;205:220-8. doi: 10.1111/j.0105-2896.2005.00255.x. Immunol Rev. 2005. PMID: 15882356 Free PMC article. Review.
-
Targeting CD40L: a promising therapeutic approach.Clin Diagn Lab Immunol. 2004 Jul;11(4):635-41. doi: 10.1128/CDLI.11.4.635-641.2004. Clin Diagn Lab Immunol. 2004. PMID: 15242934 Free PMC article. Review. No abstract available.
-
Irradiation enhances human T-cell function by upregulating CD70 expression on antigen-presenting cells in vitro.J Immunother. 2011 May;34(4):327-35. doi: 10.1097/CJI.0b013e318216983d. J Immunother. 2011. PMID: 21499130 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
